| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2052 | Phenethyl-orvinol |
2052.0010: 10 mg per vial
Please inquire for customized filling and bulk quantities. 
|
|
Reference standard for [11C]Phenethyl-orvinol
|
||
| Molar Mass: 473.60 | ||
| C30H35NO4 | ||
| [14521-98-3 | ||
| Colourless to yellowish solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: 6,14-Ethenomorphinan-7-methanol, -4,5-epoxy-6-hydroxy-α,17-dimethyl-,α-(2-phenylethyl)-3-(triphenylmethoxy)-, (5α, 7α) |
||
|
Synonymes: PEO |
||
|
Literature: Marton J. et al. Synthesis and evaluation of a full-agonist orvinol for PET-imaging of opioid receptors: [11C]PEO J. Med. Chem. 2009, 52, 5586-5589. |
||
| Hjørnevik T. et al. Spinal long-term potentiation is associated with reduced opioid neurotransmission in the rat brain. Clin. Physiol. Funct. Imaging 2010, 30, 285-293. | ||
| date of product catalogue issue: 10 May 2017 | ||